False
October 29, 2015
U.K. Ophthalmologists are the leading adopters of Oraya Therapy for the treatment of wet age-related macular degeneration (AMD), two years after the treatment was introduced in the country.
1 min read
October 29, 2015
Anti-VEGF monotherapy may not be adequate for all your wet AMD patients. The Oraya Therapy™ Stereotactic Radiotherapy for Wet AMD, intended as a one-time treatment, has been shown to maintain vision while reducing the number of anti-VEGF injections, providing a viable option for patients with significant fluid in the macula.
1 min read
October 29, 2015
Christopher Brand, Consultant Ophthalmic Surgeon, discusses the treatment of recently diagnosed wet AMD patients
1 min read
October 29, 2015
Professor Dr. Salvatore Grisanti reviews selection criteria for best outcomes using Oraya Therapy for wet AMD
1 min read
October 29, 2015
Dr. med Katja Hatz discusses the treat and extend approach to wet AMD with the Oraya Therapy
1 min read
October 29, 2015
Consultant ophthalmic surgeon Professor Tariq Aslam shares clinical insights and patient experiences with the Oraya Therapy for the treatment of wet AMD in the UK
1 min read
October 29, 2015
Professor Ian Rennie, Consultant Ophthalmologist and International Expert in Treatments of Ocular Cancers, discusses the safe use of radiotherapy for the treatment of wet AMD
1 min read
October 29, 2015
Consultant ophthalmic surgeon Timothy L. Jackson, PhD FRCOphth reviews 3-year safety data of stereotactic radiotherapy for the treatment for wet AMD
1 min read
October 29, 2015
Time-elapsed clinical images demonstrating the treatment results and impact of Oraya Therapy on wet AMD
1 min read
October 29, 2015
Time-elapsed clinical images demonstrating the treatment results and impact of Oraya Therapy on wet AMD
1 min read
False